No Data
No Data
No Data
No Data
No Data
Acasti Pharma (ACST) Gets a Buy From Craig-Hallum
TipRanksFeb 13 21:36
Acasti Pharma Q3 EPS $(0.21) Up From $(0.52) YoY
Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.21) per share. This is a 59.62 percent increase over losses of $(0.52) per share from the same period last year.
BenzingaFeb 12 21:12
Acasti Pharma 3Q Loss/Shr 21c >ACST
Acasti Pharma 3Q Loss/Shr 21c >ACST
Dow JonesFeb 12 21:06
Acasti Pharma: Projected Cash Runway Extends Into Second Calendar Qtr 2026 >ACST
Acasti Pharma: Projected Cash Runway Extends Into Second Calendar Qtr 2026 >ACST
Dow JonesFeb 12 21:01
Acasti Pharma: Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, on Track for NDA Submission Timeline >ACST
Acasti Pharma: Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, on Track for NDA Submission Timeline >ACST
Dow JonesFeb 12 21:01
Acasti Pharma Initiated at Buy by Craig-Hallum
Acasti Pharma Initiated at Buy by Craig-Hallum
Dow JonesFeb 7 22:20
No Data
No Data